This looks like a premium compounder, not a hypergrowth moonshot. Scarce capacity, strong pricing and higher AI-related
interconnection attach can drive strong operating growth, but the stock already reflects quality, so most upside must come from execution and sustained scarcity rather than another big
rerating.